SteelPeak Wealth LLC Trims Stake in CVS Health Corporation $CVS

SteelPeak Wealth LLC reduced its stake in CVS Health Corporation (NYSE:CVS) by 95.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 5,057 shares of the pharmacy operator’s stock after selling 117,739 shares during the quarter. SteelPeak Wealth LLC’s holdings in CVS Health were worth $401,000 at the end of the most recent quarter.

Several other hedge funds have also bought and sold shares of the stock. National Pension Service boosted its position in shares of CVS Health by 3.1% in the third quarter. National Pension Service now owns 3,999,622 shares of the pharmacy operator’s stock worth $301,532,000 after purchasing an additional 119,189 shares during the period. Kingsview Wealth Management LLC raised its position in shares of CVS Health by 316.2% during the 3rd quarter. Kingsview Wealth Management LLC now owns 104,432 shares of the pharmacy operator’s stock valued at $7,873,000 after purchasing an additional 79,340 shares during the period. AE Wealth Management LLC lifted its stake in shares of CVS Health by 6.2% during the 3rd quarter. AE Wealth Management LLC now owns 257,204 shares of the pharmacy operator’s stock valued at $19,391,000 after buying an additional 14,983 shares in the last quarter. Mirae Asset Global Investments Co. Ltd. boosted its holdings in CVS Health by 11.2% in the 3rd quarter. Mirae Asset Global Investments Co. Ltd. now owns 225,116 shares of the pharmacy operator’s stock worth $16,971,000 after buying an additional 22,653 shares during the period. Finally, Alpha Omega Wealth Management LLC boosted its holdings in CVS Health by 12.3% in the 3rd quarter. Alpha Omega Wealth Management LLC now owns 149,902 shares of the pharmacy operator’s stock worth $11,301,000 after buying an additional 16,418 shares during the period. Institutional investors own 80.66% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have commented on CVS. Weiss Ratings reissued a “hold (c-)” rating on shares of CVS Health in a report on Monday, December 29th. Morgan Stanley increased their target price on CVS Health from $89.00 to $93.00 and gave the stock an “overweight” rating in a research report on Wednesday, December 10th. Leerink Partners reissued an “outperform” rating and set a $98.00 target price on shares of CVS Health in a research note on Thursday, March 5th. Argus lowered their price target on CVS Health from $91.00 to $90.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Finally, Barclays increased their price objective on shares of CVS Health from $87.00 to $93.00 and gave the company an “overweight” rating in a report on Wednesday, December 10th. Twenty investment analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $94.95.

CVS Health Trading Up 0.1%

Shares of CVS Health stock opened at $73.57 on Monday. CVS Health Corporation has a twelve month low of $58.35 and a twelve month high of $85.15. The company has a quick ratio of 0.63, a current ratio of 0.84 and a debt-to-equity ratio of 0.80. The business has a 50-day moving average price of $75.74 and a 200-day moving average price of $77.73. The firm has a market cap of $93.59 billion, a price-to-earnings ratio of 53.31, a PEG ratio of 0.77 and a beta of 0.51.

CVS Health (NYSE:CVS) last posted its earnings results on Tuesday, February 10th. The pharmacy operator reported $1.09 EPS for the quarter, topping analysts’ consensus estimates of $1.00 by $0.09. CVS Health had a return on equity of 11.31% and a net margin of 0.44%.The company had revenue of $105.69 billion for the quarter, compared to the consensus estimate of $103.67 billion. During the same period in the previous year, the business earned $1.19 earnings per share. The firm’s revenue for the quarter was up 8.2% on a year-over-year basis. CVS Health has set its FY 2026 guidance at 5.940-6.140 EPS. Equities research analysts anticipate that CVS Health Corporation will post 5.89 EPS for the current fiscal year.

CVS Health Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Monday, May 4th. Stockholders of record on Thursday, April 23rd will be given a dividend of $0.665 per share. This represents a $2.66 dividend on an annualized basis and a dividend yield of 3.6%. The ex-dividend date is Thursday, April 23rd. CVS Health’s dividend payout ratio is currently 192.75%.

CVS Health Company Profile

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.